Meridien Research is proud to announce and welcome Lisa G. Campbell as Executive Director, Business Development. In this role, Campbell will be responsible for sales team leadership, driving revenue, existing and new client relationships and identifying new research opportunities where our 6 sites will play a key role in patient recruitment for Sponsors and CRO’s.
“Lisa’s previous Business Development experience is in the clinical trials services industry working with Sponsor and CRO organizations,” said Tony G. Busa, Jr., president and CEO of Meridien Research. “Her knowledge and contacts in the industry will be invaluable to Meridien Research. We are excited about the opportunities she will bring to light.”
“It’s an exciting opportunity to work with a growing organization like Meridien Research that understands the importance of meeting client timelines, along with what it takes to run a trial efficiently and effectively,” Campbell expands. “Our PI’s and sites have extensive clinical trials experience, targeted therapeutic expertise, are focused on helping patients and truly want to find new effective treatments. The leadership team is driven for results, yet appreciate the hard work and provide the atmosphere to make their team successful.”
With over 15 years in the Pharmaceutical and Life Sciences Industry, Campbell is familiar with what it takes to partner with a Sponsor or CRO from a global perspective. “I have extensive experience on both sides which can be beneficial when looking at solutions for different organizations and studies,” Campbell explains. “
Campbell most recently was the Business Development Manager for BioTelemetry, formerly Cardiocore in North Carolina. Prior to that, she worked for Medidata Solutions, Biomedical Systems, Merge Healthcare, Merck and Johnson & Johnson.
Campbell is a graduate of East Carolina University and lives in Cary, North Carolina. She can be reached at firstname.lastname@example.org.
About Meridien Research
Meridien Research has been conducting clinical research trials and studies since 2000 in Central Florida. All studies are administered by board certified doctors and highly trained medical personnel in St. Petersburg, Tampa, Bradenton, Brooksville, Lakeland and Maitland.